Oncopeptides AB Market Cap

Oncopeptides AB has a market cap or net worth of 475.56 million as of August 30, 2024. Its market cap has decreased by -25.93% in one year.

Market Cap

475.56M

Enterprise Value

207.17M

Revenue

21.37M

Ranking

n/a

PE Ratio

n/a

Stock Price

2.21

Market Cap Chart

Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 475.56M, a decrease of -71.52%. That is a compound annual growth rate of -15.37%.

Market Cap History

Date	Market Cap	% Change
Aug 30, 2024	475.56M	-34.37%
Dec 29, 2023	724.64M	-36.76%
Dec 30, 2022	1.15B	81.18%
Dec 30, 2021	632.45M	-94.51%
Dec 30, 2020	11.53B	63.96%
Dec 30, 2019	7.03B	21.37%
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Feb 22, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca PLC	2,774.87B
ABB Ltd	1,084.57B
Investor AB (publ)	933.86B
Investor AB (publ)	933.86B
Atlas Copco AB	871.62B
Atlas Copco AB	871.62B
AB Volvo (publ)	555.92B
AB Volvo (publ)	555.92B

Market Cap Rankings